Protea Biosciences Balance Sheet - Quarterly (OTCMKTS:PRGBQ)

Add to My Stocks
$0.01 $0.02 (66.67%) PRGBQ stock closing price Mar 19, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our Protea Biosciences stock analysis. As in our Protea Biosciences stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Quarterly results are typically accompanied with the company releasing financial statements. The balance sheet shows total liabilities of $14.63M and shareholders equity of $-11.8M. Protea Biosciences revenue and Protea Biosciences operating cash flow are important in understanding the financial capacity of the company.

View and download Protea Biosciences quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q22017 Q12016 Q42016 Q22016 Q12015 Q42015 Q3
Marketable Securities-------
Raw Materials-------
Work In Progress-------
Finished Goods-------
Notes Receivable-------
Other Current Assets-------
Total Current Assets
Property Plant & Equipment6.71M6.65M6.65M8.08M7.53M7.56M7.79M
Accumulated Depreciation4.41M4.31M4.18M5.24M5.08M4.93M4.94M
Net Property Plant & Equipment
Investment & Advances-------
Other Non-Current Assets-------
Deferred Charges-------
Deposits & Other Assets-------
Total Assets
Notes Payable-------
Accounts Payable1.14M1.71M1.79M1.29M1.27M1.33M1.41M
Current Portion Long-Term Debt9.15M7.98M10.1M6.11M7.7M6.89M8.69M
Current Portion Capital Leases-------
Accrued Expenses-------
Income Taxes Payable-------
Other Current Liabilities2.55M7.54M3.65M2.19M1.5M1.35M-
Total Current Liabilities
Deferred Taxes/Income-------
Convertible Debt-------
Long-Term Debt1.77M1.83M1.76M4.91M1.61M1.72M1.96M
Non-Current Capital Leases-------
Other Long-Term Liabilities-------
Total Liabilities
Minority Interest-------
Preferred Stock-------
Common Stock Net-------
Capital Surplus94.76M84.66M81.12M71.61M71.48M71.31M68.1M
Retained Earnings-106.61M-101.11M-95.24M-82.49M-80.68M-79.59M-77.6M
Treasury Stock-------
Other Liabilities-------
Shareholders Equity-11.8M-16.42M-14.1M-10.85M-9.18M-8.27M-9.48M
Total Liabilities & Shareholders Equity2.82M2.65M3.21M3.66M2.91M3.04M3.23M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our MEDPACE HLDGS financial analysis

Looking at Protea Biosciences historical stock prices and the current Protea Biosciences stock price can tell you how the stock price has moved, whereas the Protea Biosciences PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: PRGBQ total assets, which was at $2.82M for 2017 Q2 is a balance sheet item representing value of what Protea Biosciences owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Protea Biosciences's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for PRGBQ stock stand at $14.63M.

Protea Biosciences Balance Sheet - Key Ratios

Quarterly Balance Sheets For Protea Biosciences Group Inc Peers

MEDPACE HLDGS balance sheet